In the United States, prostate cancer is the most frequent cancer among males. Because of early discovery and treatment with androgen deprivation therapy, many individuals can live long lives. Despite the benefits of this treatment, almost all patients will develop medication resistance and recurrent disease at some point. Moffitt Cancer Center researchers uncover a process by which prostate cancer cells …
Read More »